In present study, we used pharmacological tools and trpv4 gene-deleted mouse models to test the hypothesis that the CYP-EET-TRPV4 pathway regulates the agonist-induced vasoconstriction in pulmonary hypertension. The gene discussed is PPIG; the disease is pulmonary hypertension.